Synapse - Adult Leukemia

Results (3720)

Clinical impact of bridging therapy prior to commercial chimeric antigen receptor (CAR) T-cell therapies for relapsed/refractory lymphomas

Meeting Abstract

Imber, B. S.; Perales, M. A.; Flynn, J.; Ruiz, J. D.; Devlin, S.; Alarcon Tomas, A.; Hajj, C.; Batlevi, C. L.; Dahi, P. B.; Lin, R. J.; more...
Blood (2020)

Fulltext@MSK | Save

ZRSR2 mutation induced minor intron retention drives MDS and diverse cancer predisposition via aberrant splicing of LZTR1

Meeting Abstract

Inoue, D.; Polaski, J. T.; Taylor, J.; Castel, P.; Chen, S.; Kobayashi, S.; Hogg, S. J.; Hayashi, Y.; Pineda, J. M. B.; Penson, A. V.; more...
Blood (2020)

Fulltext@MSK | Save

Clinical benefit of crenolanib, with or without salvage chemotherapy, in multiply relapsed, FLT3 mutant AML patients after prior treatment with gilteritinib

Meeting Abstract

Goldberg, A. D.; Geyer, M. B.; Kell, J.; Di Bona, E.; Pardee, T. S.; Bhave, R.; Grunwald, M. R.; Marconi, G.; Wang, Y. J.; Pathan, A.; more...
Blood (2020)

Fulltext@MSK | Save

Phase II study of blinatumomab and concurrent oral tyrosine kinase inhibitor therapy as consolidation and maintenance therapy for patients with Philadelphia chromosome-positive acute lymphoblastic leukemia following chemotherapy-sparing induction

Meeting Abstract

Geyer, M. B.; King, A. C.; O'Brien, J. C.; Park, J. H.
Blood (2020)

Fulltext@MSK | Save

Interplay between chromosomal alterations and gene mutations shapes the evolutionary trajectory of clonal hematopoiesis

Meeting Abstract

Gao, T.; Ptashkin, R.; Bolton, K. L.; Fong, C.; Spitzer, B.; Menghrajani, K.; Arango Ossa, J. E.; Zhou, Y.; Bernard, E.; Levine, M.; more...
Blood (2020)

Fulltext@MSK | Save

Germline contributions to clonal hematopoiesis in solid cancer patients

Meeting Abstract

Franch-Expósito, S.; Srinivasan, P.; Ptashkin, R.; Bandlamudi, C.; Bolton, K. L.; Gedvilaite, E.; Menghrajani, K.; Mandelker, D.; Comen, E.; Norton, L.; more...
Blood (2020)

Fulltext@MSK | Save

Impact of additional cytogenetic abnormalities and complex karyotype on event-free survival in acute promyelocytic leukemia: Analysis from a single academic center plus the APML4 study

Meeting Abstract

Epstein-Peterson, Z. D.; Rajeeve, S.; Derkach, A.; Park, J. H.; Stein, E. M.; Zhang, Y.; Iland, H. J.; Tallman, M. S.
Blood (2020)

Fulltext@MSK | Save

Increased interleukin-8 (IL8)-CXCR2 signaling promotes progression of bone marrow fibrosis in myeloproliferative neoplasms

Meeting Abstract

Dunbar, A.; Lu, M.; Farina, M.; Park, Y.; Yang, J.; Kim, D.; Karzai, A.; Salama, M. E.; Snyder, J.; Krishnan, A.; more...
Blood (2020)

Fulltext@MSK | Save

Molecular characterization of clinical response and relapse in patients with IDH1-mutant newly diagnosed acute myeloid leukemia treated with ivosidenib and azacitidine

Meeting Abstract

Daigle, S. R.; Choe, S.; DiNardo, C. D.; Stein, A. S.; Stein, E. M.; Fathi, A. T.; Frankfurt, O.; Schuh, A. C.; Döhner, H.; Martinelli, G.; more...
Blood (2020)

Fulltext@MSK | Save

SY-1425, a potent and selective RARα agonist, in combination with azacitidine demonstrates a high complete response rate and a rapid onset of response in RARA-positive newly diagnosed unfit acute myeloid leukemia

Meeting Abstract

De Botton, S.; Cluzeau, T.; Vigil, C. E.; Cook, R. J.; Rousselot, P.; Rizzieri, D. A.; Liesveld, J. L.; Fenaux, P.; Braun, T.; Banos, A.; more...
Blood (2020)

Fulltext@MSK | Save